Holen Sie sich die Stockscreener-App
7.75
0.77%
-0.06
Handel nachbörslich:
7.75
Schlusskurs vom Vortag:
$7.81
Offen:
$7.75
24-Stunden-Volumen:
372.79K
Relative Volume:
2.04
Marktkapitalisierung:
$165.68M
Einnahmen:
$66.59M
Nettoeinkommen (Verlust:
$-104.93M
KGV:
-1.5657
EPS:
-4.95
Netto-Cashflow:
$-96.48M
1W Leistung:
-1.15%
1M Leistung:
-10.51%
6M Leistung:
+31.80%
1J Leistung:
-27.37%
1-Tages-Spanne:
$7.59
$7.97
1-Wochen-Bereich:
$7.165
$8.01
52-Wochen-Spanne:
$4.09
$13.37
Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile
Firmenname
Enanta Pharmaceuticals Inc
Sektor
Branche
Telefon
617 607 0800
Adresse
4 KINGSBURY AVENUE, WATERTOWN, MA
Vergleichen Sie ENTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENTA
Enanta Pharmaceuticals Inc
|
7.75 | 166.96M | 66.59M | -104.93M | -96.48M | -4.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-08-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-08-08 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-10-07 | Eingeleitet | Jefferies | Buy |
| 2021-09-09 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-01-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-11-24 | Eingeleitet | Evercore ISI | Underperform |
| 2020-08-28 | Fortgesetzt | ROTH Capital | Buy |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-27 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-03-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-11-22 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-05-24 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-23 | Hochstufung | Berenberg | Hold → Buy |
| 2018-12-13 | Eingeleitet | Berenberg | Hold |
| 2018-06-06 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-01-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-11-21 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-07-11 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-04-28 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2016-02-09 | Bestätigt | Barclays | Underweight |
| 2015-10-23 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2015-10-23 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
Alle ansehen
Enanta Pharmaceuticals Inc Aktie (ENTA) Neueste Nachrichten
How to recover losses in Enanta Pharmaceuticals Inc. stockSell Signal & Safe Entry Trade Reports - newser.com
Backtesting results for Enanta Pharmaceuticals Inc. trading strategies2025 Top Decliners & Community Verified Trade Alerts - newser.com
What Fibonacci levels say about Enanta Pharmaceuticals Inc. reboundJuly 2025 Institutional & Verified Trade Idea Suggestions - newser.com
What’s next for Enanta Pharmaceuticals Inc. stock price2025 Earnings Impact & Technical Pattern Recognition Alerts - newser.com
Chart based analysis of Enanta Pharmaceuticals Inc. trendsEarnings Beat & High Accuracy Swing Entry Alerts - newser.com
Real time alert setup for Enanta Pharmaceuticals Inc. performanceJuly 2025 Opening Moves & Technical Pattern Alert System - newser.com
What’s the recovery path for long term holders of Enanta Pharmaceuticals Inc.Weekly Risk Summary & Free Daily Entry Point Trade Alerts - newser.com
Growth Recap: Whats the outlook for Enanta Pharmaceuticals Incs sectorPortfolio Gains Report & Weekly Hot Stock Watchlists - خودرو بانک
Institutional scanner results for Enanta Pharmaceuticals Inc.July 2025 Retail & Short-Term Trading Alerts - newser.com
AI Stocks: What are Enanta Pharmaceuticals Incs technical support levelsWeekly Volume Report & AI Powered Market Trend Analysis - خودرو بانک
Quantitative breakdown of Enanta Pharmaceuticals Inc. recent move2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Evercore ISI Lowers Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target to $12.00 - MarketBeat
Earnings visualization tools for Enanta Pharmaceuticals Inc.2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
Signal strength of Enanta Pharmaceuticals Inc. stock in tech scannersJuly 2025 Decliners & High Return Stock Watch Alerts - newser.com
Valuation Update: Can Enanta Pharmaceuticals Inc reach all time highs this yearJuly 2025 Institutional & Long-Term Safe Return Strategies - خودرو بانک
Best data tools to analyze Enanta Pharmaceuticals Inc. stockQuarterly Market Summary & Free High Accuracy Swing Entry Alerts - newser.com
Is Enanta Pharmaceuticals Inc. showing signs of accumulationTrade Entry Report & Safe Capital Growth Plans - newser.com
How moving averages guide Enanta Pharmaceuticals Inc. tradingMarket Activity Recap & Risk Managed Trade Strategies - newser.com
Aug Drivers: Can Enanta Pharmaceuticals Inc be recession proof2025 Market Trends & Weekly Market Pulse Alerts - خودرو بانک
Is now a turning point for Enanta Pharmaceuticals Inc.Market Growth Report & Entry Point Confirmation Alerts - newser.com
Enanta Pharmaceuticals Inc. stock retracement – recovery analysisQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Risk Hedge: Whats the outlook for Enanta Pharmaceuticals Incs sector2025 Fundamental Recap & Weekly Market Pulse Updates - خودرو بانک
Analyzing Enanta Pharmaceuticals Inc. with risk reward ratio chartsWeekly Loss Report & Low Drawdown Investment Ideas - newser.com
How to read the order book for Enanta Pharmaceuticals Inc.Quarterly Portfolio Summary & Growth-Oriented Investment Plans - newser.com
Can Enanta Pharmaceuticals Inc sustain earnings growthWeekly Volume Report & Reliable Entry Point Trade Alerts - خودرو بانک
Primary Biliary Cholangitis Market Expected to Gain Momentum Through 2034, According to DelveInsight | Intercept Pharma, Enanta Pharma, COUR Pharma, Novartis, Gannex Pharma, Nanjing Chia-tai Tianqing - Barchart.com
Trade Recap: Why is Enanta Pharmaceuticals Inc stock going upQuarterly Profit Summary & Weekly Consistent Profit Watchlists - khodrobank.com
Using AI based signals to follow Enanta Pharmaceuticals Inc.Portfolio Performance Summary & Community Trade Idea Sharing - newser.com
Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target Lowered to $12.00 at Evercore ISI - Defense World
Evercore Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Cuts Target Price to $12 - 富途牛牛
Day Trade: Is AACTWS forming bullish engulfing patternsLong Setup & AI Enhanced Trading Signals - خودرو بانک
Aug Fed Impact: Is Enanta Pharmaceuticals Inc. stock a smart retirement pickJuly 2025 Summary & Detailed Earnings Play Alerts - خودرو بانک
Evercore ISI Group Lowers Price Target for Enanta Pharma (ENTA) | ENTA Stock News - GuruFocus
Finanzdaten der Enanta Pharmaceuticals Inc-Aktie (ENTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):